Zachary Reinstein

MD-PhD Candidate at Northwestern University

[Northwestern Feinberg School of Medicine @NUFeinbergMed]

Northwestern Medicine scientists discovered increased immune cell activity in #MerkelCellCarcinoma tumors, which could help predict treatment response in patients, per @CD_AACR. https://t.co/tAVS99XpBf

[Zachary Reinstein @zzreinstein]

7/7 Key takeaway: This study identifies multiple clinically actionable biomarkers and potential therapeutic targets for MCC, with implications for other cancer types. Exciting progress in personalized immunotherapy! #PrecisionMedicine #CancerTreatment

[Zachary Reinstein @zzreinstein]

Happy to share our latest work in Merkel cell carcinoma immunotherapy published today in Cancer Discovery @CD_AACR from the Choi Lab @jaehyukchoimd in collaboration with the Tsai lab @KYTsaiLab. https://t.co/2Ns7Aioeqj

[Zachary Reinstein @zzreinstein]

6/7 Post-immunotherapy analysis shows expansion of pre-existing Trm cells and recruitment of new clones in responders. This highlights the importance of both pre-existing immunity and newly recruited T cells. #AdaptiveImmunity